Skip to main content
Clinical Trials/NCT01748474
NCT01748474
Completed
Phase 2

Effect of Short-term Oxygen Therapy on Cardiopulmonary Exercise Capacity in Patients With Pulmonary Arterial and Chronic Thromboembolic Pulmonary Hypertension

University of Zurich1 site in 1 country20 target enrollmentDecember 2012

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Pulmonary Arterial and Chronic Thromboembolic Pulmonary Hypertension
Sponsor
University of Zurich
Enrollment
20
Locations
1
Primary Endpoint
Watt
Status
Completed
Last Updated
9 years ago

Overview

Brief Summary

In a randomized, sham-controlled trial the investigators will test whether supplemental oxygen given during cardiopulmonary exercise testing will improve exercise performance and physiological parameters in patients with pulmonary arterial or chronic thromboembolic pulmonary hypertension.

Registry
clinicaltrials.gov
Start Date
December 2012
End Date
July 2016
Last Updated
9 years ago
Study Type
Interventional
Study Design
Crossover
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Watt

Time Frame: 1 day

exercise time

Time Frame: 1 day

Secondary Outcomes

  • Peak oxygen uptake(1 day)
  • Respiratory exchange ratio(1 day)
  • ventilatory equivalent of carbon dioxide (VE/VCO2) slope(1 day)
  • end-tidal pressures of carbon dioxide (PET CO2)(1 day)
  • Changes in arterial blood parameters(1 day)

Study Sites (1)

Loading locations...

Similar Trials